|
1
|
Liu X, Zhang W, Guo H, Yue J and Zhuo S:
miR-98 functions as a tumor suppressor in salivary adenoid cystic
carcinomas. Onco Targets Ther. 9:1777–1786. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tang Y, Liang X, Zheng M, Zhu Z, Zhu G,
Yang J and Chen Y: Expression of c-kit and Slug correlates with
invasion and metastasis of salivary adenoid cystic carcinoma. Oral
Oncol. 46:311–316. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
He JF, Ge MH, Zhu X, Chen C, Tan Z, Li YN
and Gu ZY: Expression of RUNX3 in salivary adenoid cystic
carcinoma: Implications for tumor progression and prognosis. Cancer
Sci. 99:1334–1340. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hu K, Gan YH, Li SL, Gao Y, Wu DC, Wang CY
and Yu GY: Relationship of activated extracellular signal-regulated
kinase 1/2 with lung metastasis in salivary adenoid cystic
carcinoma. Oncology Rep. 21:137–143. 2009.
|
|
5
|
Qian X, Kaufmann AM, Chen C, Tzamalis G,
Hofmann VM, Keilholz U, Hummel M and Albers AE: Prevalence and
associated survival of high-risk HPV-related adenoid cystic
carcinoma of the salivary glands. Int J Oncol. 49:803–811. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li S, Zhang X, Zhou Z and Huang Z, Liu L
and Huang Z: Downregulation of nucleophosmin expression inhibited
proliferation and induced apoptosis in salivary gland adenoid
cystic carcinoma. J Oral Pathol Med. 46:175–181. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sun L, Liu B, Lin Z, Yao Y, Chen Y, Li Y,
Chen J, Yu D, Tang Z, Wang B, et al: miR-320a acts as a prognostic
factor and Inhibits metastasis of salivary adenoid cystic carcinoma
by targeting ITGB3. Mol Cancer. 14:962015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dong YL, Zhou L, Li YL, Xiao K and Weng
XS: Establishment and assessment of rat models of
glucocorticoid-induced osteonecrosis. Zhongguo Yi Xue Ke Xue Yuan
Xue Bao. 37:152–156. 2015.PubMed/NCBI
|
|
9
|
Mirzaei H, Gholamin S, Shahidsales S,
Sahebkar A, Jaafari MR, Mirzaei HR, Hassanian SM and Avan A:
MicroRNAs as potential diagnostic and prognostic biomarkers in
melanoma. Eur J Cancer. 53:25–32. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong
C, Huang Y, Hu X, Su F, Lieberman J and Song E: let-7 regulates
self renewal and tumorigenicity of breast cancer cells. Cell.
131:1109–1123. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Couzin J: Cancer biology. A new cancer
player takes the stage. Science. 310:766–767. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu MX, Zhou KC and Cao Y: MCRS1
overexpression, which is specifically inhibited by miR-129*,
promotes the epithelial-mesenchymal transition and metastasis in
non-small cell lung cancer. Mol Cancer. 13:2452014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiang LH, Ge MH, Hou XX, Cao J, Hu SS, Lu
XX, Han J, Wu YC, Liu X, Zhu X, et al: miR-21 regulates tumor
progression through the miR-21-PDCD4-Stat3 pathway in human
salivary adenoid cystic carcinoma. Lab Invest. 95:1398–1408. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Martin del Campo SE, Latchana N, Levine
KM, Grignol VP, Fairchild ET, Jaime-Ramirez AC, Dao TV, Karpa VI,
Carson M, Ganju A, et al: miR-21 enhances melanoma invasiveness via
inhibition of tissue inhibitor of metalloproteinases 3 expression:
In vivo effects of miR-21 inhibitor. PLoS One. 10:e01159192015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Leone E, Morelli E, Di Martino MT, Amodio
N, Foresta U, Gullà A, Rossi M, Neri A, Giordano A, Munshi NC, et
al: Targeting miR-21 inhibits in vitro and in vivo multiple myeloma
cell growth. Clin Cancer Res. 19:2096–2106. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu Y, Kanwar SS, Patel BB, Oh PS, Nautiyal
J, Sarkar FH and Majumdar AP: MicroRNA-21 induces stemness by
downregulating transforming growth factor beta receptor 2 (TGFβR2)
in colon cancer cells. Carcinogenesis. 33:68–76. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang BG, Li JF, Yu BQ, Zhu ZG, Liu BY and
Yan M: microRNA-21 promotes tumor proliferation and invasion in
gastric cancer by targeting PTEN. Oncol Rep. 27:1019–1026. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen W, Liu BY, Zhang X, Zhao XG, Cao G,
Dong Z and Zhang SL: Identification of differentially expressed
genes in salivary adenoid cystic carcinoma cells associated with
metastasis. Arch Med Sci. 12:881–888. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Feng X, Matsuo K, Zhang T, Hu Y, Mays AC,
Browne JD, Zhou X and Sullivan CA: MicroRNA profiling and target
genes related to metastasis of salivary adenoid cystic carcinoma.
Anticancer Res. 37:3473–3481. 2017.PubMed/NCBI
|
|
21
|
Cai L, Chen Q, Fang S, Lian M and Cai M:
MicroRNA-329 inhibits cell proliferation and tumor growth while
facilitates apoptosis via negative regulation of KDM1A in gastric
cancer. J Cell Biochem. Nov 11–2017. View Article : Google Scholar
|
|
22
|
Rammer M, Webersinke G, Haitchi-Petnehazy
S, Maier E, Hackl H, Charoentong P, Malli T, Steinmair M, Petzer AL
and Rumpold H: MicroRNAs and their role for T stage determination
and lymph node metastasis in early colon carcinoma. Clin Exp
Metastasis. Nov 13–2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fu LL, Li CJ, Xu Y, Li LY, Zhou X, Li DD,
Chen SX, Wang FG, Zhang XY and Zheng LW: Role of lncRNAs as novel
biomarkers and therapeutic targets in ovarian cancer. Crit Rev
Eukaryot Gene Expr. 27:183–195. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Takahasi K, Iinuma H, Wada K, Minezaki S,
Kawamura S, Kainuma M, Ikede Y, Shibuya M, Miura F and Sano K:
Usefulness of exosome-encapsulated microRNA-451a as a minimally
invasive biomarker for prediction of recurrence and prognosis in
pancreatic ductal adenocarcinoma. J Hepatobiliary Pancreat Sci. Nov
11–2017. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen W, Zhao X, Dong Z, Cao G and Zhang S:
Identification of microRNA profiles in salivary adenoid cystic
carcinoma cells during metastatic progression. Oncol Lett.
7:2029–2034. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shi GH, Ye DW, Yao XD, Zhang SL, Dai B,
Zhang HL, Shen YJ, Zhu Y, Zhu YP, Xiao WJ and Ma CG: Involvement of
microRNA-21 in mediating chemo-resistance to docetaxel in
androgen-independent prostate cancer PC3 cells. Acta Pharmacol Sin.
31:867–873. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Alder H, Taccioli C, Chen H, Jiang Y,
Smalley KJ, Fadda P, Ozer HG, Huebner K, Farber JL, Croce CM and
Fong LY: Dysregulation of miR-31 and miR-21 induced by zinc
deficiency promotes esophageal cancer. Carcinogenesis.
33:1736–1744. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Connolly EC, Van Doorslaer K, Rogler LE
and Rogler CE: Overexpression of miR-21 promotes an in vitro
metastatic phenotype by targeting the tumor suppressor RHOB. Mol
Cancer Res. 8:691–700. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liao J, Liu R, Shi YJ, Yin LH and Pu YP:
Exosome-shuttling microRNA-21 promotes cell migration and
invasion-targeting PDCD4 in esophageal cancer. Int J Oncol.
48:2567–2579. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ma G, Zhang H, Dong M, Zheng X, Ozaki I,
Matsuhashi S and Guo K: Downregulation of programmed cell death 4
(PDCD4) in tumorigenesis and progression of human digestive tract
cancers. Tumor Biol. 34:3879–3885. 2013. View Article : Google Scholar
|
|
31
|
Wang D, Guo S, Han SY, Xu N, Guo JY and
Sun Q: Distinct roles of different fragments of PDCD4 in regulating
the metastatic behavior of B16 melanoma cells. Int J Oncol.
42:1725–1733. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Motoyama K, Inoue H, Mimori K, Tanaka F,
Kojima K, Uetake H, Sugihara K and Mori M: Clinicopathological and
prognostic significance of PDCD4 and microRNA-21 in human gastric
cancer. Int J Oncol. 36:1089–1095. 2010.PubMed/NCBI
|
|
33
|
Cao Z, Yoon JH, Nam SW, Lee JY and Park
WS: PDCD4 expression inversely correlated with miR-21 levels in
gastric cancers. J Cancer Res Clin Oncol. 138:611–619. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Asangani IA, Rasheed SA, Nikolova DA,
Leupold JH, Colburn NH, Post S and Allgayer H: MicroRNA-21 (miR-21)
post-transcriptionally downregulates tumor suppressor Pdcd4 and
stimulates invasion, intravasation and metastasis in colorectal
cancer. Oncogene. 27:2128–2136. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shi L, Chen JA, Yang JA, Pan TH, Zhang SG
and Wang ZM: miR-21 protected human glioblastoma U87MG cells from
chemotherapeutic drug temozolomide induced apoptosis by decreasing
Bax/Bcl-2 ratio and caspase-3 activity. Brain Res. 1352:255–264.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sizemore GM, Balakrishnan S, Hammer AM,
Thies KA, Trimboli AJ, Wallace JA, Sizemore ST, Kladney RD, Woelke
SA, Yu L, et al: Stromal PTEN inhibits the expansion of mammary
epithelial stem cells through Jagged-1. Oncogene. 36:2297–2308.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Upton DH, Walters KA, Allavena RE, Jimenez
M, Desai R, Handelsman DJ and Allan CM: Global or granulosa
cell-specific pten mutations in combination with elevated fsh
levels fail to cause ovarian tumours in mice. Horm Cancer.
7:316–326. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Krohn A, Diedler T, Burkhardt L, Mayer PS,
De Silva C, Meyer-Kornblum M, Kötschau D, Tennstedt P, Huang J,
Gerhäuser C, et al: Genomic deletion of PTEN is associated with
tumor progression and early PSA recurrence in ERG fusion-positive
and fusion-negative prostate cancer. Am J Pathol. 181:401–412.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xue X, Liu Y, Wang Y, Meng M, Wang K, Zang
X, Zhao S, Sun X, Cui L, Pan L and Liu S: miR-21 and miR-155
promote non-small cell lung cancer progression by downregulating
SOCS1, SOCS6, and PTEN. Oncotarget. 7:84508–84519. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu H, Du L, Wang R, Wei C, Liu B, Zhu L,
Liu P, Liu Q, Li J, Lu SL and Xiao J: High frequency of loss of
PTEN expression in human solid salivary adenoid cystic carcinoma
and its implication for targeted therapy. Oncotarget.
6:11477–11491. 2015.PubMed/NCBI
|
|
41
|
Ettl T, Gosau M, Brockhoff G,
Schwarz-Furlan S, Agaimy A, Reichert TE, Rohrmeier C, Zenk J and
Iro H: Predictors of cervical lymph node metastasis in salivary
gland cancer. Head Neck. 36:517–523. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang X, Zhang T, Yang K, Zhang M and Wang
K: miR-486-5p suppresses prostate cancer metastasis by targeting
Snail and regulating epithelial-mesenchymal transition. OncoTargets
Ther. 9:6909–6914. 2016. View Article : Google Scholar
|
|
43
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
